We are live on ! Find out more
OPCM

Osborne Partners Capital Management Portfolio holdings

AUM $1.8B
1-Year Est. Return 22.23%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+22.23%
3 Year Est. Return
+60.75%
5 Year Est. Return
+67.79%
10 Year Est. Return
+286.62%
AUM
$703M
AUM Growth
+$4.58M
Cap. Flow
-$5.78M
Cap. Flow %
-0.82%
Top 10 Hldgs %
26.67%
Holding
184
New
7
Increased
75
Reduced
46
Closed
3

Top Buys

Rank Stock Value
1
LYB icon
LyondellBasell Industries
LYB
+$3.13M
2
SHPG
Shire pic
SHPG
+$3.08M
3
SYF icon
Synchrony
SYF
+$2.57M
4
AVGO icon
Broadcom
AVGO
+$2.1M
5
DNOW icon
DNOW Inc
DNOW
+$742K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$5.93M
2
BG icon
Bunge Global
BG
+$4.27M
3
PYPL icon
PayPal
PYPL
+$3.79M
4
APAM icon
Artisan Partners
APAM
+$3.35M
5
CNC icon
Centene
CNC
+$2.78M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.48%
3 Financials 11.49%
4 Consumer Staples 8.7%
5 Industrials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MON
101
DELISTED
Monsanto Co
MON
$1.1M 0.16%
9,330
VZ icon
102
Verizon
VZ
$194B
$1.09M 0.15%
24,352
-77
-0.3% -$3.59K
ED icon
103
Consolidated Edison
ED
$39.9B
$1.08M 0.15%
13,428
DUK icon
104
Duke Energy
DUK
$96.5B
$1.06M 0.15%
12,645
D icon
105
Dominion Energy
D
$58.6B
$988K 0.14%
12,895
+1,400
+12% +$110K
HCSG icon
106
Healthcare Services Group
HCSG
$1.52B
$979K 0.14%
20,900
GXP
107
DELISTED
Great Plains Energy Incorporated
GXP
$894K 0.13%
30,541
-300
-1% -$8.73K
PBE icon
108
Invesco Biotechnology & Genome ETF
PBE
$287M
$807K 0.11%
17,670
BAC icon
109
Bank of America
BAC
$439B
$780K 0.11%
32,166
+628
+2% +$14.6K
VTI icon
110
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
$777K 0.11%
6,242
+81
+1% +$9.98K
YUMC icon
111
Yum China
YUMC
$16.5B
$729K 0.1%
18,480
AMG icon
112
Affiliated Managers Group
AMG
$9.9B
$696K 0.1%
4,196
+21
+0.5% +$3.35K
DNB
113
DELISTED
Dun & Bradstreet
DNB
$669K 0.1%
6,185
PNW icon
114
Pinnacle West Capital
PNW
$12.2B
$636K 0.09%
7,465
SCHW
115
Charles Schwab
SCHW
$187B
$608K 0.09%
14,161
+90
+0.6% +$3.6K
APU
116
DELISTED
AmeriGas Partners, L.P.
APU
$608K 0.09%
13,453
-100
-0.7% -$4.49K
APD icon
117
Air Products & Chemicals
APD
$66.6B
$550K 0.08%
3,845
NVS icon
118
Novartis
NVS
$293B
$544K 0.08%
7,269
-83,725
-92% -$5.93M
MRK icon
119
Merck
MRK
$317B
$512K 0.07%
8,380
-3,797
-31% -$231K
BRK.A icon
120
Berkshire Hathaway Class A
BRK.A
$1.13T
$509K 0.07%
2
SPGI icon
121
S&P Global
SPGI
$119B
$474K 0.07%
3,250
MMM icon
122
3M
MMM
$93.1B
$473K 0.07%
2,717
+26
+1% +$4.35K
QQQ icon
123
Invesco QQQ Trust
QQQ
$479B
$470K 0.07%
3,417
-78
-2% -$10.7K
VB icon
124
Vanguard Morningstar Small-Cap ETF
VB
$81.4B
$468K 0.07%
3,455
+1,647
+91% +$221K
META icon
125
Meta Platforms (Facebook)
META
$1.5T
$462K 0.07%
3,058
+285
+10% +$42.4K

Similar funds

Osborne Partners Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Osborne Partners Capital Management held 184 positions worth $703M, up 0.66% from $698M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Osborne Partners Capital Management's Q2 2017 filing shows 7 new, 75 increased, 46 reduced and 3 closed positions. Its largest new stake was Broadcom: 90,320 shares worth $2.1M. The largest sale was Novartis, an estimated $5.93M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Osborne Partners Capital Management's largest Q2 2017 buy was Broadcom: 90,320 shares worth $2.1M.
  • Osborne Partners Capital Management added most to LyondellBasell Industries in Q2 2017, an estimated $3.13M increase.
  • Osborne Partners Capital Management's biggest Q2 2017 reduction was Novartis, cutting an estimated $5.93M.
  • Osborne Partners Capital Management fully exited Artisan Partners in Q2 2017, selling an estimated $3.35M.
  • Osborne Partners Capital Management's ten largest holdings make up 27% of its $703M portfolio in Q2 2017.
  • Osborne Partners Capital Management opened 7 new positions and closed 3 in Q2 2017.
  • Osborne Partners Capital Management's portfolio value rose 0.66% quarter-over-quarter to $703M.

Based on Osborne Partners Capital Management's 13F filing for Q2 2017, filed 24 Jul 2017.